HepTech began in the life and body of its founder, Todd Schneider, who was born a hemophiliac. He was infected with Hepatitis C and Hepatitis B virus at 2 years old from a blood transfusion, but he did not find out that he was infected until age 30. By then, he had already developed cirrhosis. He had been taking supplements at that time of diagnosis, but the doctors were unfamiliar with their effect, and told him to stop. His health immediately declined, and got even worse when he was given Interferon. It was clear that his life would be short if he followed the medical recommendations, so he started doing his own research. In his search for a personal cure, he talked with doctors and patients -- anyone who claimed to have a cure for Hep C. But, before he took them seriously, he asked to see their laboratory results. Every claim of cure and every test of a new remedy, showed that virus was still present. So, he changed his strategy, and began to ask, "How can the disease be managed? He continued his study of the scientific literature and contacted the people who had done the research. This led him to Dr. Peter Schmid, MD, PhD, a doctor, researcher, inventor who has devoted much of his life to the study of liver health and Hepatitis C. Dr. Schmid developed a protocol to counteract the HCV- induced damage by controlling the inflammation caused the HCV infection. His goal was to stop the inflammation, that lead to cell death and fibrosis. This would allow the liver to then use its regenerative capability to restore liver function. His protocol includes phytochemicals, vitamins, minerals, and amino acids to produce the anti-inflammatory effects. We put his theory to the test by recommending it to a cohort of patients with Hepatitis C. The results were positive; in fact, some of the stories of recovery were near-miraculous. The level of anecdotal response was so strong that we contracted with Dr. Lorne Tyrrell, a world renown researcher at the University of Alberta, to conduct an animal study to see how the liver ...
View Top Employees from Hepatitis Technologies IncWebsite | https://heptech.com |
Revenue | $3 million |
Employees | View employees |
Address | 999 S Washington St, North Attleboro, Massachusetts 02760, US |
Phone | (403) 529-0289 |
Fax | (403) 504-4513 |
Industry | Wellness and Fitness Services, Hospitals & Clinics, Healthcare |
Competitors | Revelation Health LLC, Treat Holdings |
SIC | SIC Code 80 Companies, SIC Code 809 Companies |
NAICS | NAICS Code 62 Companies, NAICS Code 62199 Companies, NAICS Code 6219 Companies, NAICS Code 621 Companies |
Looking for a particular Hepatitis Technologies Inc employee's phone or email?
The Hepatitis Technologies Inc annual revenue was $3 million in 2024.
Hepatitis Technologies Inc is based in North Attleboro, Massachusetts.
The NAICS codes for Hepatitis Technologies Inc are [62, 62199, 6219, 621].
The SIC codes for Hepatitis Technologies Inc are [80, 809].